Literature DB >> 30579274

Ablation dynamics of subsequent thermal doses delivered to previously heat-damaged tissue during magnetic resonance-guided laser-induced thermal therapy.

Sean M Munier, Eric L Hargreaves, Nitesh V Patel, Shabbar F Danish.   

Abstract

OBJECTIVE: Intraoperative dynamics of magnetic resonance-guided laser-induced thermal therapy (MRgLITT) have been previously characterized for ablations of naive tissue. However, most treatment sessions require the delivery of multiple doses, and little is known about the ablation dynamics when additional doses are applied to heat-damaged tissue. This study investigated the differences in ablation dynamics between naive versus damaged tissue.
METHODS: The authors examined 168 ablations from 60 patients across various surgical indications. All ablations were performed using the Visualase MRI-guided laser ablation system (Medtronic), which employs a 980-nm diffusing tip diode laser. Cases with multiple topographically overlapping doses with constant power were selected for this study. Single-dose intraoperative thermal damage was used to calculate ablation rate based on the thermal damage estimate (TDE) of the maximum area of ablation achieved (TDEmax) and the total duration of ablation (tmax). We compared ablation rates of naive undamaged tissue and damaged tissue exposed to subsequent thermal doses following an initial ablation.
RESULTS: TDEmax was significantly decreased in subsequent ablations compared to the preceding ablation (initial ablation 227.8 ± 17.7 mm2, second ablation 164.1 ± 21.5 mm2, third ablation 124.3 ± 11.2 mm2; p = < 0.001). The ablation rate of subsequent thermal doses delivered to previously damaged tissue was significantly decreased compared to the ablation rate of naive tissue (initial ablation 2.703 mm2/sec; second ablation 1.559 mm2/sec; third ablation 1.237 mm2/sec; fourth ablation 1.076 mm/sec; p = < 0.001). A negative correlation was found between TDEmax and percentage of overlap in a subsequent ablation with previously damaged tissue (r = -0.164; p < 0.02).
CONCLUSIONS: Ablation of previously ablated tissue results in a reduced ablation rate and reduced TDEmax. Additionally, each successive thermal dose in a series of sequential ablations results in a decreased ablation rate relative to that of the preceding ablation. In the absence of a change in power, operators should anticipate a possible reduction in TDE when ablating partially damaged tissue for a similar amount of time compared to the preceding ablation.

Entities:  

Keywords:  GBM = glioblastoma multiforme; GLM = generalized linear model; MRTI = magnetic resonance thermal imaging; MRgLITT; MRgLITT = magnetic resonance–guided laser-induced thermal therapy; TDE = thermal damage estimate; magnetic resonance thermometry; magnetic resonance–guided laser thermal therapy; thermal ablation; tmax = ablation duration

Mesh:

Year:  2018        PMID: 30579274     DOI: 10.3171/2018.7.JNS18886

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  180-W GreenLight laser photoselective vaporization with multiple triamcinolone acetonide injections for the treatment of bladder neck contractures.

Authors:  Xiaoliang Sun; Xunbo Jin; Kang Leng; Yong Zhao; Haiyang Zhang
Journal:  Lasers Med Sci       Date:  2022-05-02       Impact factor: 2.555

Review 2.  Hyperthermia treatment advances for brain tumors.

Authors:  Georgios P Skandalakis; Daniel R Rivera; Caroline D Rizea; Alexandros Bouras; Joe Gerald Jesu Raj; Dominique Bozec; Constantinos G Hadjipanayis
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

Review 3.  In vitro evidence for glioblastoma cell death in temperatures found in the penumbra of laser-ablated tumors.

Authors:  Joshua D Frenster; Shivang Desai; Dimitris G Placantonakis
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

Review 4.  Laser Interstitial Thermal Therapy for Posterior Fossa Lesions: A Systematic Review and Analysis of Multi-Institutional Outcomes.

Authors:  Mohammadmahdi Sabahi; Stephen J Bordes; Edinson Najera; Alireza M Mohammadi; Gene H Barnett; Badih Adada; Hamid Borghei-Razavi
Journal:  Cancers (Basel)       Date:  2022-01-17       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.